AGM Details

The 43rd Annual General Meeting of Medi-Caps Limited is scheduled to be held on Tuesday, 22nd September 2026 at 12:30 P.M. (IST) through Video Conference (VC)/Other Audio Visual Means (OAVM). The registered office of the company at Indore shall be deemed as the venue for the meeting.

Business to be Transacted

Ordinary Businesses:

1. (a) Adoption of Audited Standalone Financial Statements for the financial year ended 31st March 2026, together with Reports of Board of Directors and Auditors, Management Discussion Analysis, and Corporate Governance Report.

2. (b) Adoption of Audited Consolidated Financial Statements for the financial year ended 31st March 2026, together with Reports of Auditors.

Special Businesses:

3. Re-appointment of Mr. Alok K Garg (DIN: 00274321) as Chairman and Managing Director and payment of remuneration - Special Resolution

  • Proposed term: 01st September 2026 to 31st August 2029 (3 years)
  • Salary: ₹7,00,000 per month (Rupees Seven Lakhs only)
  • Perquisites: Restricted to 25% of annual salary, including furnished accommodation/HRA, gas, electricity, water, furniture, chauffeur-driven car, telephone, medical reimbursement, insurance policies, leave benefits, club fees, provident fund, superannuation fund, ex-gratia, and gratuity
  • Provisions for payment in case of inadequate profits as per Schedule V of Companies Act, 2013
  • Board authorized to vary terms within overall managerial remuneration limits

4. Confirmation of appointment of Mrs. Saloni Garg (DIN: 11865402) as Director and Whole-Time Woman Director - Special Resolution

  • Appointment as Additional Director effective from 07th August 2026
  • Proposed term as Whole-Time Woman Director: 07th August 2026 to 06th August 2029 (3 years)
  • Salary: ₹2,00,000 per month (Rupees Two Lakhs only)
  • Perquisites: Restricted to 25% of annual salary, with benefits similar to Mr. Alok K Garg
  • Provisions for payment in case of inadequate profits as per Schedule V
  • Board authorized to vary terms within overall managerial remuneration limits

Financial Performance Disclosure (as per Explanatory Statement)

The explanatory statement provides financial performance indicators:

| Financial Year | Revenue from Operations (₹ lakh) | Profit/(Loss) Before Tax (₹ lakh) | Profit/(Loss) After Tax (₹ lakh) |

| 2025-2026 | 230.59 | (12.46) | (13.87) |

| 2024-2025 | 241.66 | 28.50 | 55.51 |

| 2023-2024 | 716.54 | 482.73 | 388.82 |

Background Information on Appointees

Mr. Alok K Garg

  • Current Designation: Managing Director (term ending 31st March 2027)
  • Qualifications: MBA (Marketing), Diploma in Export Documentation & Implementation from Indian Institute of Foreign Trade, Delhi
  • Experience: Over 26 years in pharmaceutical industry and real estate sector
  • Current Remuneration: ₹7.00 lakh per month as Managing Director
  • Shareholding: 32,74,866 equity shares (26.26%)
  • Relationships: Father of Mr. Akshit Garg (CFO), Father-in-law of Mrs. Saloni Garg
  • Board Meeting Attendance: Attended all 4 meetings during FY 2025-2026

Mrs. Saloni Garg

  • Current Designation: Senior Manager (appointed Additional Director on 07th August 2026)
  • Qualifications: Graduate in Business Management from Mumbai, Master's in Brand Management from Italy
  • Experience: Freelance Brand Manager with expertise in brand identity, logos, websites, and communication design
  • Current Remuneration: ₹2.00 lakh per month as Senior Manager
  • Shareholding: Does not hold any shares in the company
  • Relationships: Daughter-in-law of Mr. Alok K Garg, Wife of Mr. Akshit Garg (CFO)

Regulatory Compliance Details

  • Filed pursuant to Regulation 30 read with Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • AGM conducted through VC/OAVM in compliance with MCA Circulars and SEBI Circulars permitting virtual meetings
  • Electronic voting facility provided through Central Depository Services (India) Limited (CDSL)
  • Cut-off date for determining voting rights: Tuesday, 15th September 2026
  • Remote e-voting period: Saturday, 19th September 2026 (9:00 AM) to Monday, 21st September 2026 (5:00 PM)
  • Scrutinizer: Ms. Darshika Wankhede, Practicing Company Secretary (ACS-79800; CP No. 28624)

Shareholder Services Information

  • Registrar & Share Transfer Agent: Ankit Consultancy Private Limited, Indore
  • Investor grievance email: investors@medicaps.com
  • Documents available for inspection at registered office during working hours
  • Physical shareholders urged to dematerialize holdings due to SEBI mandate for dematerialized transfers
  • KYC compliance mandatory for processing any investor service requests

Corporate Governance Aspects

  • Board composition: One Managing Director and three Independent Directors
  • No director liable to retire by rotation as per Article 98(1) of Articles of Association
  • All resolutions require shareholder approval through special resolution process
  • Related party transactions disclosed: Mr. Alok K Garg related to Mr. Akshit Garg (CFO) and Mrs. Saloni Garg